215 related articles for article (PubMed ID: 11702599)
1. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
Fassas AB; Tricot G
Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
[No Abstract] [Full Text] [Related]
2. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.
Pedersen-Bjergaard J; Andersen MK; Christiansen DH
Blood; 2000 Jun; 95(11):3273-9. PubMed ID: 10828005
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.
Duong VH; Holtzman NG; Koka R; Singh ZN; Zou Y; Emadi A; Rapoport AP; Kocoglu MH; Baer MR; Badros AZ
Leuk Lymphoma; 2019 Dec; 60(14):3577-3580. PubMed ID: 31282234
[No Abstract] [Full Text] [Related]
4. Treatment of therapy-related leukemia and myelodysplastic syndrome.
Kantarjian HM; Estey EH; Keating MJ
Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Metayer C; Curtis RE; Vose J; Sobocinski KA; Horowitz MM; Bhatia S; Fay JW; Freytes CO; Goldstein SC; Herzig RH; Keating A; Miller CB; Nevill TJ; Pecora AL; Rizzo JD; Williams SF; Li CY; Travis LB; Weisdorf DJ
Blood; 2003 Mar; 101(5):2015-23. PubMed ID: 12393427
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma.
Traweek ST; Slovak ML; Nademanee AP; Brynes RK; Niland JC; Forman SJ
Leuk Lymphoma; 1996 Feb; 20(5-6):365-72. PubMed ID: 8833391
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer.
Nichols G; de Castro K; Wei LX; Griffin M; Lin N; Oratzi A; Murty VV; Troxel A; Vahdat L; Hesdorffer C
Leukemia; 2002 Sep; 16(9):1673-9. PubMed ID: 12200680
[TBL] [Abstract][Full Text] [Related]
8. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
9. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
10. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Anderson JE; Gooley TA; Schoch G; Anasetti C; Bensinger WI; Clift RA; Hansen JA; Sanders JE; Storb R; Appelbaum FR
Blood; 1997 Apr; 89(7):2578-85. PubMed ID: 9116305
[TBL] [Abstract][Full Text] [Related]
11. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
Smith SM; Le Beau MM; Huo D; Karrison T; Sobecks RM; Anastasi J; Vardiman JW; Rowley JD; Larson RA
Blood; 2003 Jul; 102(1):43-52. PubMed ID: 12623843
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum?
Sill H; Olipitz W; Schimek MG
J Clin Oncol; 2005 Nov; 23(31):8120-1; author reply 8121-2. PubMed ID: 16258113
[No Abstract] [Full Text] [Related]
13. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Hosing C; Munsell M; Yazji S; Andersson B; Couriel D; de Lima M; Donato M; Gajewski J; Giralt S; Körbling M; Martin T; Ueno NT; Champlin RE; Khouri IF
Ann Oncol; 2002 Mar; 13(3):450-9. PubMed ID: 11996478
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplasia and acute leukemia after autologous bone marrow transplantation.
Armitage JO
J Clin Oncol; 2000 Mar; 18(5):945-6. PubMed ID: 10694542
[No Abstract] [Full Text] [Related]
15. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
16. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
[No Abstract] [Full Text] [Related]
17. Early myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloid leukemia.
Muroi K; Kawano C; Yokote T; Otsuki T; Kirito K; Komatsu N; Ozawa K
Leuk Lymphoma; 2002 Jul; 43(7):1493-6. PubMed ID: 12389635
[TBL] [Abstract][Full Text] [Related]
18. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
[TBL] [Abstract][Full Text] [Related]
19. Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
Deeg HJ; Socie G
Blood; 1998 Mar; 91(6):1833-44. PubMed ID: 9490664
[No Abstract] [Full Text] [Related]
20. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
Venugopal P; Manson S; Preisler HD
Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
